Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2015

View Archived Issues

Anika Therapeutics forms strategic collaboration with the Institute for Applied Life Sciences

Vect-Horus establishes scientific collaboration with Servier

OWC Pharmaceutical Research presents lab results on CBD/THC combinations for multiple myeloma

AstraZeneca announces two collaborations in diabetes and chronic kidney disease

IRICoR and CCRM partner to launch spin off ExCellThera

GSK to create independent research institute

ARCA biopharma closes private placement financing round

Pembrolizumab receives U.S. orphan drug status for gastric cancer

Phase I protocol presented for a recessive dystrophic epidermolysis bullosa gene therapy

Radiolabeled chemokine receptor-targeting peptides as inflammation tracers

Radioiodinated therapeutic monoclonal antibody developed as an oncological tracer

GALGT2 gene therapy named FDA orphan drug for Duchenne muscular dystrophy

TapImmune gains additional funding

Mutations identified in three retinal dystrophy genes related o retinitis pigmentosa

Emulate deploys Organs-on-Chips platform across Janssen programs

Kyoto University describes new NK-3R agonists

Laboratorio Farmaceutico CT patents gamma-hydroxybutyric acid prodrugs

Canbex Therapeutics develops CB1 receptor agonists

Results of phase III study of biosimilar infliximab in patients with rheumatoid arthritis

Pfizer divulges JAK3 inhibitors

UCLB reports development of HIF-1alpha inhibitors

European Commission approves Opdivo for advanced melanoma

FDA approves Fycompa as adjunctive treatment for primary generalized tonic-clonic seizures

ReNeuron and Benitec extend research collaboration

Global ALS Day: New avenues in research

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026